Insider purchased substantial shares of Atea Pharmaceuticals on July 23, 2025.
1 report, 1 independent
Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider purchased substantial shares of Atea Pharmaceuticals on July 23, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Atea Pharmaceuticals (United States)
company in Boston, United States
Coverage
Newest first; wire copies grouped- Simply Wall St.Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m In the last year, multiple insiders have substantially increased their holdings of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) stock, ind